explore -WSS

explore

author：Wikipedia 2025-10-02 00:28:19 - browse：86

Electrocardiogram in the shape of the United States map — Adobe

The market for artificial intelligence in health care is about as transparent as a brick wall. New tools achieve impressive results in published studies. But it is often difficult to compare them head to head with similar products, or tell whether they will work on different kinds of patients.

A new company is promising to change that — if it can convince AI developers to expose their products to more rigorous testing.

Called Dandelion Health, the New York-based firm is launching a first-of-its-kind public service to evaluate AI products on independent data designed to root out weaknesses and reveal bias. The company said Wednesday its initial pilot program, to begin next month, will focus on testing algorithms that use electrocardiograms to predict heart conditions.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： As demand for Covid shots wanes, Moderna seeks its next success
Next article： Abortion pill mifepristone to soon be dispensed at CVS, Walgreens

WSS

International team creates first chimeric human

ALS groups 'won't be played again' by the FDA, drug sponsors

Clinical trials giant ICON acquires HumanFirst

Abortion pill mifepristone to soon be dispensed at CVS, Walgreens

Clinical trials must include more disabled people

Living with Hashimoto's and celiac disease, and med school, too

focus

explore

hotspot

Virginia high school admissions case could be legal follow

Abortion pill mifepristone to soon be dispensed at CVS, Walgreens

After affirmative action ruling, medical educators look to 'holistic review'

Hilary may become 1st tropical storm to make landfall in California in 84 years

Walensky prepares to leave CDC — and Congress — behind

Abortion pill mifepristone to soon be dispensed at CVS, Walgreens

BioMarin wins approval for gene therapy to treat hemophilia A

ALS groups 'won't be played again' by the FDA, drug sponsors

Affirmative action in medical school literally saved lives

ALS groups 'won't be played again' by the FDA, drug sponsors

leisure time

RaDonda Vaught to speak at CommonSpirit event on patient safety

Why getting cancer drugs just got harder for rural patients

Covid isolation guidance eased by the CDC

Patient advocates sound warning on FDA proposal on salt intake

Beware the threat of staffing cuts at the CDC

Pfizer highlights cancer drugs it thinks could reignite investor interest

hotspot

hotspot

explore

explore